Novavision Group SpA   Report issue

For profit
Founded: Misinto Italy (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
2019
NCT03857893
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

NOVAVISION GROUP S.P.A

Active Ingredients

Drugs in Other Trials (1)

cetearyl alcohol (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1